<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-vaccines-08-00197">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stepanova</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Kotlyarov</surname>
    <given-names>R.Y.</given-names>
   </name>
   <name>
    <surname>Kovaleva</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Potapchuk</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Korotkov</surname>
    <given-names>A.V.</given-names>
   </name>
   <name>
    <surname>Sergeeva</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Kasianenko</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Kuprianov</surname>
    <given-names>V.V.</given-names>
   </name>
   <name>
    <surname>Ravin</surname>
    <given-names>N.V.</given-names>
   </name>
   <name>
    <surname>Tsybalova</surname>
    <given-names>L.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin</article-title>
  <source>PLoS ONE</source>
  <year>2015</year>
  <volume>10</volume>
  <elocation-id>e0119520</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0119520</pub-id>
  <pub-id pub-id-type="pmid">25799221</pub-id>
 </element-citation>
</ref>
